Massive 10,000-Patient study seeks best Post-Surgery treatment path for lung cancer
NCT ID NCT07256002
Summary
This study looks back at the medical records of 10,000 lung cancer patients who received immunotherapy before surgery. Researchers want to understand which follow-up treatments after surgery lead to the best survival rates and identify markers that predict which patients need additional therapy. The goal is to help doctors make better decisions about post-surgery care for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100020, China
Conditions
Explore the condition pages connected to this study.